Volume 60, Issue 4 pp. 238-241
Article
Full Access

Antitumor activity of cis-diamminedichloroplatinum (II) depends on its time × concentration product against human gastric cancer cell lines in vitro

Naoto Kurihara MD

Naoto Kurihara MD

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Search for more papers by this author
Tetsuro Kubota MD

Corresponding Author

Tetsuro Kubota MD

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Department of Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, JapanSearch for more papers by this author
Yasunori Hoshiya MD

Yasunori Hoshiya MD

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Search for more papers by this author
Yoshihide Otani MD

Yoshihide Otani MD

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Search for more papers by this author
Koichiro Kumai MD

Koichiro Kumai MD

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Search for more papers by this author
Masaki Kitajima MD, FACS

Masaki Kitajima MD, FACS

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Search for more papers by this author
First published: December 1995
Citations: 12

Abstract

A pharmacodynamic study of cisplatin (DDP) was conducted using the gastric cancer cell lines MKN-45 and MKN-74 in vitro. Ten thousand tumor cells were incubated with 0.4–500 μg/ml DDP for 1–25 h, followed by recovery culture for a further 48 h. At the end of incubation, cell viability was detected by the MTT end-point, and the inhibition rate was compared in relation to the incubation time, DDP concentration, and the time × concentration product (area under the curve in vitro: AUC vitro). In both of the cell lines, the IC50 and IC90 values decreased as the exposure time increased, going a linear curve with a slope of almost — 1, and showing a typical log-log AUC vitro-dependent curve. These results indicate that the antitumor activity of DDP is dependent on its AUC vitro, suggesting the clinical usefulness of this drug when administered daily in small divided doses. © 1995 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.